异性食道炎和胃炎的单克隆抗体:系统性审查和元分析
Qunoot Irfan1, Syed Muhammad Mehdi Zaidi1, Mustafa Hassan Alvi2
1Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Journal of clinical gastroenterology
|September 17, 2025
概括
单克隆抗体,如dupilumab,有效地降低埃索诺菲尔,并改善埃索诺菲尔食道炎 (EoE) 的食道症状. 这些治疗方法也对乙酸性胃炎 (EoG) 有希望,尽管需要更多的研究.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙性食道炎 (EoE) 是一种慢性免疫疾病,导致食道炎症和像失症这样的症状.
- 乙酸性胃炎 (EoG) 与EoE共享炎症途径,但对治疗疗效的证据有限.
- 目前对EoE的治疗方法往往无法实现缓解,这凸显了针对2型炎症的新疗法的需要.
研究的目的:
- 系统地审查和元分析单克隆抗体在治疗EoE中的疗效和安全性.
- 进行对EoG单克隆抗体研究的系统审查.
- 评估这些生物治疗对关键临床和组织学标志物的影响.
主要方法:
- 根据PRISMA指南进行了系统审查和元分析.
- 搜索包括到2025年6月的PubMed,Cochrane和Embase数据库.
- 主要结局:高氨基酸细胞峰值数的变化;次要结局:内镜评分,不良事件.
主要成果:
- 包括八个eoe的RCT (865名参与者) 和eog的三个RCT (155名参与者).
- 单克隆抗体显著降低了高氨基细胞的峰值计数 (MD-59.17) 和改善了内镜参考评分 (EREFS).
- 杜皮卢马布表现出最强的疗效,副作用与安慰剂相当. 发现偏差风险较低.
结论:
- 单克隆抗体,特别是dupilumab,通过降低乙酸细胞数量和改善EREFS,有效地管理EoE.
- 有证据表明,EoG也有类似的益处,但有限的RCT阻止了元分析.
- 需要进行更大规模的标准化试验来确认研究结果,并评估这两种疾病的长期结果.
更多相关视频
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Gastroesophageal Reflux Disease II: Clinical Features and Management
705
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
705
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
944
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
944
Peptic Ulcer Disease IV: Management
439
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
439
Barrett Esophagus-II: Clinical Manifestations and Management
802
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
802
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K


